PTC Therapeutics board approves $500M share repurchase program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 64.62 +3.74 (6.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.88 | 52 Week High | $35.40 | |||
| Open | $64.14 | 52 Week Low | $4.03 | |||
| Day High | $64.98 | P/E | 6.87 | |||
| Day Low | $63.16 | EPS | $9.40 | |||
| Volume | 265,790 | |||||
